Scientists Are Gaining On RSV, a Persistent Threat to Children
“We think we have a vaccine that really can be a very important solution to prevent serious respiratory disease associated with R.S.V. in older adults,” said Dr. Phil Dormitzer, who leads vaccine development at GSK. Several research teams are working on vaccines for young children. One group, led by Dr. Coleen Cunningham, pediatrician in chief…
Details